NYSE:HLF • KYG4412G1010
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HERBALIFE LTD (HLF).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-19 | Citigroup | Maintains | Buy -> Buy |
| 2026-01-08 | Mizuho | Maintains | Neutral -> Neutral |
| 2026-01-06 | Maxim Group | Initiate | Buy |
| 2025-12-12 | Citigroup | Maintains | Buy -> Buy |
| 2025-11-26 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-11-26 | Argus Research | Upgrade | Hold -> Buy |
| 2025-07-28 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-05-01 | Citigroup | Maintains | Buy -> Buy |
| 2025-03-21 | DA Davidson | Upgrade | Neutral -> Buy |
| 2025-02-20 | DA Davidson | Maintains | Neutral -> Neutral |
| 2024-11-01 | Mizuho | Maintains | Neutral -> Neutral |
| 2024-10-31 | DA Davidson | Maintains | Neutral -> Neutral |
| 2024-10-31 | B. Riley Securities | Maintains | Buy -> Buy |
| 2024-10-25 | Citigroup | Maintains | Buy -> Buy |
| 2024-08-01 | DA Davidson | Maintains | Neutral -> Neutral |
| 2024-08-01 | B. Riley Securities | Maintains | Buy -> Buy |
| 2024-06-07 | Mizuho | Maintains | Neutral -> Neutral |
| 2024-05-02 | DA Davidson | Maintains | Neutral -> Neutral |
| 2024-03-25 | DA Davidson | Maintains | Neutral -> Neutral |
| 2024-03-21 | Mizuho | Maintains | Neutral -> Neutral |
| 2024-03-21 | B of A Securities | Maintains | Underperform -> Underperform |
| 2024-02-16 | Mizuho | Maintains | Neutral -> Neutral |
| 2023-11-29 | Mizuho | Maintains | Neutral -> Neutral |
| 2023-09-14 | DA Davidson | Initiate | Neutral |
| 2023-08-03 | Mizuho | Maintains | Neutral -> Neutral |
| 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.062B -2.73% | 4.993B -1.37% | 5.038B 0.89% | 5.285B 4.91% | 5.491B 3.90% | |
| EBITDA YoY % growth | 542.6M -20.49% | 594.9M 9.64% | 619.7M 4.17% | 691.77M 11.63% | 728.33M 5.28% | |
| EBIT YoY % growth | 429.3M -24.29% | 473.5M 10.30% | 498.5M 5.28% | 545.76M 9.48% | 584M 7.01% | |
| Operating Margin | 8.48% | 9.48% | 9.90% | 10.33% | 10.64% | |
| EPS YoY % growth | 2.21 -34.81% | 1.96 -11.31% | 2.13 8.67% | 2.57 20.74% | 2.96 14.96% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 0.56 -5.76% | 0.63 7.25% | 0.66 31.70% | 0.55 21.20% |
| Revenue Q2Q % growth | 1.289B 5.51% | 1.322B 5.00% | 1.323B 3.87% | 1.358B 5.85% |
| EBITDA Q2Q % growth | 165.77M -28.98% | 178.74M -27.37% | 177.51M -18.76% | 159.47M 115.86% |
| EBIT Q2Q % growth | 129.65M -36.04% | 139.07M -24.79% | 141.67M 11.90% | 127.66M 111.33% |
All data in USD
9 analysts have analysed HLF and the average price target is 17.34 USD. This implies a price increase of 12.09% is expected in the next year compared to the current price of 15.47.
HERBALIFE LTD (HLF) will report earnings on 2026-04-28.
The consensus EPS estimate for the next earnings of HERBALIFE LTD (HLF) is 0.56 USD and the consensus revenue estimate is 1.29B USD.
The number of analysts covering HERBALIFE LTD (HLF) is 9.